Show simple item record

FieldValueLanguage
dc.contributor.authorByambasuren, Oyungerelen
dc.contributor.authorCardona, Magnoliaen
dc.contributor.authorBell, Katy J.L.en
dc.contributor.authorClark, Justinen
dc.contributor.authorMcLaws, Mary-Louiseen
dc.contributor.authorGlasziou, Paulen
dc.date.accessioned2020-06-18
dc.date.available2020-06-18
dc.date.issued2020en
dc.identifier.urihttps://hdl.handle.net/2123/22541
dc.description.abstractBackground: The prevalence of true asymptomatic COVID-19 cases is critical to policy makers considering the effectiveness of mitigation measures against the SARS-CoV-2 pandemic. We aimed to synthesize all available research on the asymptomatic rates and transmission rates where possible. Methods: We searched PubMed, Embase, Cochrane COVID-19 trials, and Europe PMC (which covers pre-print platforms such as MedRxiv). We included primary studies reporting on asymptomatic prevalence where: (a) the sample frame includes at-risk population, and (b) there was sufficiently long follow up to identify pre-symptomatic cases. Meta-analysis used fixed effect and random effects models. We assessed risk of bias by combination of questions adapted from risk of bias tools for prevalence and diagnostic accuracy studies. Results: We screened 2,454 articles and included 13 low risk-of-bias studies from seven countries that tested 21,708 at-risk people, of which 663 were positive and 111 were asymptomatic. Diagnosis in all studies was confirmed using a RT-PCR test. The proportion of asymptomatic cases ranged from 4% to 41%. Meta-analysis (fixed effect) found that the proportion of asymptomatic cases was 17% (95% CI: 14%–20%) overall; higher in aged care 20% (14%–27%), and lower in non-aged care 16% (13%–20%). Five studies provided direct evidence of forward transmission of the infection by asymptomatic cases. Overall, there was a 42% lower relative risk of asymptomatic transmission compared to symptomatic transmission (combined Relative Risk: 0.58; 95% CI 0.335–0.994, p = 0.047). Discussion: Our estimates of the prevalence of asymptomatic COVID-19 cases and asymptomatic transmission rates are lower than many highly publicized studies, but still sufficient to warrant policy attention. Further robust epidemiological evidence is urgently needed, including in sub-populations such as children, to better understand the importance of asymptomatic cases for driving spread of the pandemic.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleEstimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysisen
dc.typePreprinten
dc.identifier.doi10.1101/2020.05.10.20097543
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.